InvestorsHub Logo
icon url

jbog

11/05/10 11:35 AM

#108182 RE: tinkershaw #108180

Tinkershaw


That is simply not Teva's business, to develop complex, sophisticated drugs. That is not a slight against Teva, it is just not their business and their core competencies.



Historically speaking you are correct. Their future does hold numerious new drugs, some from their labs and some from partners.
icon url

biomaven0

11/05/10 11:39 AM

#108183 RE: tinkershaw #108180

>>Copaxone

True Teva did not invent the drug. They started funding it after Bornstein's initial US trial in the 1980's (using frozen drug supplied by the Weizmann Institute). But Teva did the heavy lifting in the decade thereafter, including the large multi-center trial using a non-frozen version and all the manufacturing and stability issues related to a one-of-a-kind drug. So what they did there is certainly a much greater commitment than for a generic enox.

Obviously Teva's focus has not been branded drugs. But that does now seem to be changing to a degree.

Peter